PWEClass II
Computerized Behavioral Therapy Device For Substance Use Disorders
21 CFR 882.5801 / Neurology
PWE is the FDA product code for Computerized Behavioral Therapy Device For Substance Use Disorders, a class II device type, regulated under 21 CFR 882.5801. FDA's definition for this code reads: "The device is intended to provide cognitive behavioral therapy to treat substance use disorder". As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and 2 recalls.
Classification record
- Product code
- PWE
- Device name
- Computerized Behavioral Therapy Device For Substance Use Disorders
- FDA definition
- The device is intended to provide cognitive behavioral therapy to treat substance use disorder.
- Regulation
- 21 CFR 882.5801
- Device class
- Class II
- Review panel
- Neurology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 2
- Ingested recalls
- 2
Clearances, product code PWE
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
Applicants with the most clearances
Product code PWE| Applicant | Clearances |
|---|---|
| Pear Therapeutics, Inc. | 2 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
